China flexes regulatory muscle at rabies vax maker

A human rabies vaccine made by the Wuhan Institute of Biological Products in central China has been voluntarily recalled, according to China's drug regulator. High levels of an endotoxin were found in one batch, which had been packaged into nearly 11,000 doses.

The SFDA estimates that more than 8,000 of the doses had been used. No adverse events have been reported.

Last month, the SFDA fined a unit of Simcere Pharmaceutical $3.75 million for producing substandard human rabies vaccine. And the unit had to cover the cost of re-vaccination, another $3.4 million.

- here's the article

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.